Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cellular Dynamics International Inc.

Division of Fujifilm Holdings Corp.
www.cellulardynamics.com

Latest From Cellular Dynamics International Inc.

Fujifilm Promises A Shake-Up Of Regenerative Medicines Market

Fujifilm has successfully transformed its business strategy by expanding away from traditional photographic film and toward new priority business fields – significantly in regenerative medicine. Identifying health care as a key growth area, Fujifilm targets the role of being a comprehensive provider in the fields of prevention, diagnosis and treatment.

Regenerative Medicine Regenerative Medicine

Cynata Sets Stage For Global Fujifilm Cell Therapy Deal

Cynata has inched closer to a major global partnership after signing a term sheet with Fujifilm for cell therapy technologies that has been described by analysts as a potentially transformative deal.

Regenerative Medicine Deals

Deals Shaping The Medical Industry, December 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in November 2015.

BioPharmaceutical Medical Device

Declaration Of Independence: Perlstein Lab Goes Solo Against Rare Diseases

Unable to land an academic job and unwilling to work in industry, Ethan Perlstein is using 21st-century tools to bootstrap his rare-disease drug discovery platform. But can he raise a million dollars?

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Cardiovascular
  • Hepatic (Liver)
  • Neurology, Nervous System
  • Alias(es)
  • iPS Cells Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Fujifilm Holdings Corp.
  • Senior Management
  • Kazuyoshi J Hirao , Chmn. & CEO
    Timothy Daley, VP, CFO
    Emile F Nuwaysir, PhD, Pres. & COO
    Chris Parker, EVP, Chief Bus. Officer
    Nicholas J Seay , VP, Chief Tech. Officer
  • Contact Info
  • Cellular Dynamics International Inc.
    Phone: (608) 310-5100
    525 Science Dr.
    Madison, WI 53711
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register